Administering [177Lu] Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localised prostate cancer (LuTectomy): a single-centre, single-arm, phase 1/2 …

RS Eapen, JP Buteau, P Jackson, C Mitchell, SF Oon… - European Urology, 2024 - Elsevier
Background High-risk localised prostate cancer (HRCaP) has high rates of biochemical
recurrence;[177 Lu] Lu-PSMA-617 is effective in men with advanced prostate cancer …
被引用次数：15 相关文章

Administering [177Lu] Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase …

RS Eapen, JP Buteau, P Jackson… - European …, 2024 - mahidol.elsevierpure.com
Background: High-risk localised prostate cancer (HRCaP) has high rates of biochemical
recurrence;[177 Lu] Lu-PSMA-617 is effective in men with advanced prostate cancer …

Administering [177Lu] Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase …

RS Eapen, JP Buteau, P Jackson, C Mitchell… - European … - pubmed.ncbi.nlm.nih.gov
Background High-risk localised prostate cancer (HRCaP) has high rates of biochemical
recurrence;[177 Lu] Lu-PSMA-617 is effective in men with advanced prostate cancer …